Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Studies using labelled C. parvum preparations in mice.

M T Scott

    Developments in Biological Standardization
    |April 13, 1977
    PubMed
    Summary

    The study tracked Corynebacterium parvum distribution in mice. Intravenous injection led to widespread organ distribution, while subcutaneous injection localized the bacteria near the injection site and draining lymph node.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tumour-induced specific suppression: a limitation to immunotherapy.

    Immunology today·2014
    Same author

    Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity.

    Oncogene·2009
    Same author

    Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding.

    The Journal of biological chemistry·2001
    Same author

    Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967. The UK Cystic Fibrosis Survey Management Committee.

    Thorax·1999
    Same author

    Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee.

    Archives of disease in childhood·1998
    Same author

    Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee.

    Archives of disease in childhood·1998

    Area of Science:

    • Immunology
    • Microbiology
    • Pharmacokinetics

    Background:

    • Corynebacterium parvum (C. parvum) is an immunomodulatory agent with potential therapeutic applications.
    • Understanding its in vivo distribution is crucial for optimizing treatment strategies and predicting efficacy.
    • Previous studies have provided limited information on the biodistribution of C. parvum following different administration routes.

    Purpose of the Study:

    • To investigate the in vivo distribution of radiolabeled and fluorescently labeled C. parvum in mice after intravenous (i.v.) and subcutaneous (s.c.) administration.
    • To determine the preferential accumulation sites of C. parvum in various organs and tissues.
    • To explore the possibility of recruiting C. parvum-containing cells into the peritoneal cavity.

    Main Methods:

    • Mice were injected intravenously (i.v.) or subcutaneously (s.c.) with 125I or fluorescein-labeled C. parvum.
    • Tissue distribution was assessed by measuring radioactivity or fluorescence in organs (liver, spleen, lungs, lymph nodes, bone marrow) and peritoneal cells.
    • Peritoneal cells were recruited using i.p. injection of thioglycollate or syngeneic tumor cells.

    Main Results:

    • Following i.v. injection, significant amounts of C. parvum were detected in the liver, spleen, and lungs, with lower concentrations in lymph nodes and bone marrow.
    • Subcutaneous injection resulted in localized distribution, with the majority of C. parvum retained at the injection site and draining lymph node; minimal amounts reached the liver and spleen.
    • C. parvum was not found in peritoneal cells after i.v. injection, but could be recruited into the peritoneal cavity by i.p. administration of thioglycollate or tumor cells.

    Conclusions:

    • The route of administration significantly influences the biodistribution of C. parvum in mice.
    • Intravenous administration leads to systemic distribution, primarily in reticuloendothelial organs, while subcutaneous administration results in localized effects.
    • C. parvum-containing cells can be recruited to the peritoneal cavity, suggesting potential for localized immunotherapy or drug delivery strategies.

    Related Experiment Videos